Si-Bone (SIBN) reported strong Q4 2025 financial results, with EPS of -$0.04 significantly beating the -$0.12 forecast and revenue reaching $56.3 million, exceeding expectations of $54.7 million. The company achieved a 15% revenue growth year-over-year, positive cash flow, and positive adjusted EBITDA for the first time, leading to a modest 0.97% increase in stock price. Looking ahead, Si-Bone projects continued revenue growth by FY2026 and plans to expand product offerings and market penetration, especially with new products like INTRA Ti and strategic partnerships.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Earnings call transcript: Si-Bone Q4 2025 reports strong revenue growth and EPS beat
Si-Bone (SIBN) reported strong Q4 2025 financial results, with EPS of -$0.04 significantly beating the -$0.12 forecast and revenue reaching $56.3 million, exceeding expectations of $54.7 million. The company achieved a 15% revenue growth year-over-year, positive cash flow, and positive adjusted EBITDA for the first time, leading to a modest 0.97% increase in stock price. Looking ahead, Si-Bone projects continued revenue growth by FY2026 and plans to expand product offerings and market penetration, especially with new products like INTRA Ti and strategic partnerships.